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A Role for G-CSF Receptor Signaling
in the Regulation of Hematopoietic Cell Function
but Not Lineage Commitment or Differentiation
defining the hematopoietic (class I) cytokine receptor
family. In contrast, outside of conserved box 1 and box
2 motifs, the intracellular domains of these receptors
share little sequence homology. Since it is generally
accepted that the signal transduction function of hema-
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topoietic cytokine receptors is localized to the intracellu-Washington University School of Medicine
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dicts that unique signals specific to each receptor are
generated.
The most cited example of the specificity of hemato-Summary
poietic cytokine signals is their ability to direct hemato-
poietic differentiation into a particular lineage (as pre-To investigate the specificity of cytokine signals in
dicted by the instructive model). For example, whenhematopoietic differentiation, we generated mice with
cultured in the presence of G-CSF, the multipotentiala targeted mutation of their G-CSF receptor (G-CSFR)
hematopoietic cell line LGM-1 acquires many featuressuch that the cytoplasmic (signaling) domain of the
associated with terminally differentiated granulocytesG-CSFR is replaced with the cytoplasmic domain of
(Yoshikawa et al., 1995). However, substantial data inthe erythropoietin receptor. In homozygous mutant
support of the stochastic model also exist. First, sup-mice, expression of this chimeric receptor had no ap-
pression of apoptosis by ectopic bcl-2 expression inparent affect on lineage commitment and was able
certain cell lines results in hematopoietic differentiationto support the production of morphologically mature
in the absence of added cytokines (Fairbairn et al., 1993;neutrophils. However, mutant neutrophils displayed
Rodel and Link, 1996; Lagasse and Weissman, 1997).reduced chemotaxis, and G-CSF-stimulated mobiliza-
Second, in many cases, enforced ectopic expressiontion of neutrophils and hematopoietic progenitors
of cytokine receptors in primary murine hematopoieticfrom the bone marrow to blood was markedly im-
progenitors allows for ligand-dependent differentiationpaired. Thus, the G-CSFR is generating unique signals
(McArthur et al., 1994; Socolovsky et al., 1997; Jacob etthat are required for certain specialized hematopoietic
al., 1998). For example, transduction of primary erythroidcell functions but are not required for granulocytic
progenitor cells with a retrovirus encoding either fordifferentiation or lineage commitment.
c-fms or for the nonhematopoietic prolactin receptor
allows for the generation of erythroid colonies in re-Introduction
sponse to macrophage colony-stimulating factor or pro-
lactin, respectively (McArthur et al., 1994; SocolovskyHematopoietic cytokines play an important role in the
et al., 1997). Finally, studies of mice carrying targeted
regulation of hematopoiesis. The best characterized bio-
null mutations of the G-CSF (Liu et al., 1996), erythropoi-
logical activity of hematopoietic cytokines is their ability
etin (Wu et al., 1995; Lin et al., 1996), or thrombopoietin
to stimulate the growth and survival of hematopoietic receptors (Alexander et al., 1996; Carver-Moore et al.,
cells. More controversial is the role that hematopoietic 1996) have shown that the production of the relevant
cytokines play in directing lineage commitment and ter- lineage-committed progenitors is largely preserved (al-
minal differentiation. Two general models for the role though reduced numbers of megakaryocyte progenitors
of cytokines in hematopoietic differentiation have been are present in thrombopoietin receptor±deficient mice).
proposed (reviewed in D'Andrea, 1994). In the instruc- The G-CSF receptor (G-CSFR) and erythropoietin re-
tive model, cytokines transmit specific signals to multi- ceptor (EpoR) are members of the hematopoietic cyto-
potential hematopoietic cells directing their lineage kine receptor superfamily. The G-CSFR is expressed in
commitment and differentiation. In the stochastic model, multipotential hematopoietic progenitors and in cells of
lineage commitment and terminal differentiation are the myeloid lineage, and it is the major cytokine receptor
intrinsically determined with cytokines providing only regulating granulopoieis (McKinstry et al., 1997). The
growth and survival signals. The final, and perhaps least EpoR is expressed primarily on erythroid progenitors
well characterized, biological activity of hematopoietic and is required for the development of definitive erythro-
cytokines is their ability to modulate mature hematopoi- poiesis (Wu et al., 1995). Although the signal transduc-
etic cell function. For example, both granulocyte colony- tion pathways utilized by these receptors share many
stimulating factor (G-CSF) and granulocyte-macrophage common features, certain signaling intermediates are
colony-stimulating factor (GM-CSF) activate certain ef- preferentially activated. For example, signal transducer
fector functions in mature neutrophils. and activator of transcription-3 (STAT-3) is prominently
All of the biological activities of hematopoietic cyto- activated by the G-CSFR but not EpoR (Tian et al., 1994;
kines are mediated through interaction with specific cell Nicholson et al., 1995; Feger et al., 1997). Despite these
surface receptors. These receptors share extensive differences, both the G-CSFR and EpoR support the
structural similarity in their extracellular domain, thus proliferation and survival of a wide range of hematopoi-
etic cell lines.
To investigate the specificity of hematopoietic cyto-* To whom correspondence should be addressed (e-mail: dlink@
im.wustl.edu). kine receptor signals in hematopoietic differentiation,
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we generated mice with a targeted (ªknockinº) mutation Cell surface expression of G:EpoR on hematopoietic
cells from GE/GE mice was analyzed using a quantitativeof their G-CSFR such that the exons encoding for the
flow cytometric method to detect specific binding ofcytoplasmic (signaling) domain of the G-CSFR are re-
biotinylated G-CSF; this assay correlates well with radio-placed with the cytoplasmic domain of the EpoR. These
isotopic binding assays for G-CSFR and can be appliedmice are predicted to express, in a myeloid-specific
to heterogeneous cell populations (Shinjo et al., 1995).fashion, a chimeric receptor (G:EpoR) that is activated
Specific G-CSF binding was detected on GE/GE neutro-by G-CSF but transduces EpoR-specific signals. We
phils (Figure 1C) but not lymphocytes (data not shown),show that, in homozygous mutant mice, G:EpoR expres-
indicating myeloid-specific expression. The level ofsion does not redirect hematopoiesis into the erythroid
G-CSF binding seen with GE/GE neutrophils was modestlylineage and is able to support the production of mor-
reduced to approximately 80% of that seen with wild-phologically mature neutrophils. Surprisingly, certain
type (1/1) neutrophils but similar to that seen with het-G-CSF-stimulated biological activities were markedly
erozygous G-CSFR-deficient (1/2) mice. The reducedimpaired, indicating that G:EpoR signals are not com-
level of G-CSF binding to GE/GE neutrophils suggestspletely redundant with those normally generated by the
either a decrease in receptor expression or in receptorG-CSFR. Thus, the G-CSFR is generating unique signals
affinity for ligand. To resolve these possibilities, we per-that are required for certain specialized hematopoietic
formed ligand-binding studies on 1/1 and GE/GE bonecell functions but are not required for granulocytic differ-
marrow cells using radiolabeled G-CSF. The calculatedentiation.
dissociation constants (Kd) for 1/1 and GE/GE cells
were similar (40 and 55 pM, respectively) and are consis-Results
tent with previously published data for wild-type murine
G-CSFR (Nicola and Metcalf, 1985; Watanabe et al.,Generation of G:EpoR Mutant Mice
1991). Collectively, these data suggest that the numberTo examine the role that growth factor signals play in
of chimeric receptors is modestly reduced on GE/GEthe lineage commitment and terminal differentiation of
neutrophils but their binding affinity for G-CSF is normal.hematopoietic progenitor cells, we generated a chimeric
To control for the effect of reduced G:EpoR cell surfacereceptor comprised of the extracytoplasmic (ligand-
expression on G-CSF-dependent responses, heterozy-binding) and transmembrane domains of G-CSFR and
gous G-CSFR-deficient mice were included in subse-the cytoplasmic (signaling) domain of the EpoR. This
quent experiments.chimeric receptor (G:EpoR) is predicted to transduce
EpoR-specific signals in a G-CSF-dependent manner.
G:EpoR Mutant Mice Have an Isolated DefectConsistent with this prediction, we previously showed
in Granulopoiesis
that primary murine hematopoietic progenitors express-
Examination of peripheral blood at 5 weeks of age re-
ing the G:EpoR specifically bound G-CSF and exhibited
vealed no significant differences in white blood cell, red
G-CSF-dependent growth (Jacob et al., 1998).
blood cell, or platelet counts between GE/GE, 1/1, 1/2,
To analyze the affects of G:EpoR expression in a more
and homozygous G-CSFR-deficient (2/2) mice (data
physiological context, we generated mice carrying a
not shown). Furthermore, leukocyte differentials re-
targeted (knockin) mutation of their G-CSFR gene such vealed no significant differences in circulating lympho-
that the exons encoding for the cytoplasmic domain of cytes, eosinophils, or monocytes (data not shown).
the G-CSFR (exons 16 and 17) were replaced with a However, GE/GE mice are neutropenic with levels of
cDNA encoding the cytoplasmic domain of the murine circulating neutrophils approximately 15% that of
EpoR (Figure 1A). The fidelity of the knockin mutation G-CSFR 1/1 mice (absolute neutrophil count [31029/L 6
was verified by sequence analysis of PCR-amplified ge- SD]: GE/GE mice, 0.11 6 0.07; 1/1 mice, 0.81 6 .52;
nomic DNA isolated from mutant mice (data not shown). 1/2 mice, 0.63 6 0.20; 2/2 mice, 0.12 6 0.05; p , 0.01
Mice carrying the G:EpoR allele are produced at the GE/GE compared with 1/1 and 1/2 mice).
expected Mendelian frequencies. Homozygous G:EpoR We next examined hematopoiesis in the bone marrow.
(GE/GE) mice develop normally, have normal reproduc- Similar numbers of total nucleated cells were recovered
tive ability, and are grossly indistinguishable from their from the bone marrow of mice of each genotype (Table
wild-type littermates. 1). GE/GE mice demonstrated a modest but significant
To analyze expression of the mutant allele, a competi- decrease in mature granulocytes to approximately 70%
tive reverse transcriptase-polymerase chain reaction that of G-CSFR 1/1 mice. Importantly, no accumula-
(RT-PCR) assay using a single set of primers that flank tion of granulocytic precursors, indicative of a block in
the mutated region was performed on RNA isolated from granulocytic differentiation, was observed. The number
bone marrow mononuclear cells (Figure 1B). As ex- and morphology of the erythroid, megakaryocytic, and
pected, only mutant G-CSFR mRNA was detected in lymphoid lineages in the bone marrow was within normal
mice homozygous for the G:EpoR allele (GE/GE); the ranges. Collectively, these data suggest GE/GE mice
reduced signal seen with GE/GE RNA is not a consistent have an isolated defect in granulopoiesis.
finding. More importantly, with RNA isolated from het-
erozygous G:EpoR mutant mice (1/GE), similar amounts G:EpoR Expression Does Not Affect
of wild-type and G:EpoR products were observed, sug- Lineage Commitment
gesting that the alleles are expressed at similar levels. Based on the expression patterns of wild-type G-CSFR
These data also indicate that the presence of the neomy- (McKinstry et al., 1997), G:EpoR is expected to be ex-
cin phosphotransferase gene in the 39-untranslated re- pressed in primitive multipotent progenitors. To deter-
gion of the mutant G-CSFR gene does not significantly mine whether altered signaling by G:EpoR in these pro-
genitors affected their lineage commitment, the numberaffect mRNA expression from the mutant allele.
Role of Cytokines in Hematopoiesis
155
Figure 1. Generation and Expression of the
G:EpoR Allele
(A) Targeting strategy. The genomic organi-
zation of the 39 region of the murine G-CSFR
gene is shown in the upper panel. Coding
exons are shown as black boxes and the 39
untranslated region as a hatched box. The
transmembrane and cytoplasmic domains of
the G-CSFR are encoded by exon 15 or exons
16 and 17, respectively. Following homolo-
gous recombination with the targeting vector,
exon 16 and the coding region of exon 17 of
the G-CSFR are replaced by a cDNA fragment
containing the cytoplasmic domain of the mu-
rine erythropoietin receptor (EpoR, lightly
stippled). Note that the PGK-Neo selection
cassette is retained in the 39 untranslated re-
gion of the G:EpoR allele.
(B) RT-PCR. A competitive RT-PCR assay us-
ing a single set of primers that flank the mu-
tated region was performed on RNA isolated
from bone marrow mononuclear cells of wild-
type (1/1), heterozygous G:EpoR (1/GE),
and homozygous G:EpoR (GE/GE) mice. The
position of the expected amplicons after aga-
rose gel electrophoresis for wild-type G-CSFR
(628 bp) and G:EpoR (778 bp) mRNAs is indi-
cated. Lanes 1, 3, and 5 are controls without
reverse transcriptase.
(C) Flow cytometric analysis. Peripheral blood
leukocytes isolated from 1/1, heterozy-
gous G-CSFR-deficient (1/2), homozygous
G-CSFR-deficient (2/2), or GE/GE mice were
incubated with biotinylated G-CSF in the ab-
sence (solid line) or presence (broken line) of a
100-fold molar excess of nonlabeled G-CSF;
specific binding of biotinylated G-CSF is rep-
resented by the difference between the two
curves. Results shown are gated on the neu-
trophil population. As expected, 2/2 neutro-
phils did not demonstrate specific G-CSF
binding.
and cytokine responsiveness of lineage-committed he- marrow of GE/GE mice was similar to that seen with
1/1, 1/2, or 2/2 mice (Figure 2). To determine whethermatopoietic progenitor cells was examined. The fre-
quency of BFU-E, CFU-GM, or CFU-GEMM in the bone G:EpoR was able to support granulocytic differentiation,
Table 1. Bone Marrow Analysis
Nucleated Cell Type 1/1 (% 6 SD) 1/2 (% 6 SD) 2/2 (% 6 SD) GE/GE (% 6 SD)
Total nucleated cells (31026) (per femur) 28.1 6 6.0 32.9 6 5.8 34.8 6 4.9 29.4 6 5.6
Band and segmented neutrophil 22.2 6 2.6 23.1 6 4.3 9.2 6 1.7a 15.0 6 1.4a,b
Metamyelocyte neutrophil 4.1 6 1.1 4.4 6 0.6 2.4 6 0.6 4.1 6 1.2
Myelocyte neutrophil 3.3 6 0.9 2.6 6 0.3 1.9 6 0.6 3.2 6 0.7
Promyelocytes 1.8 6 0.5 1.2 6 0.2 1.0 6 0.4 1.6 6 0.5
Myeloblasts 0.1 6 0.0 0.1 6 0.1 0.1 6 0.1 0.1 6 0.1
Eosinophil lineage 3.0 6 0.5 3.0 6 1.1 2.7 6 1.4 2.9 6 1.1
Lymphoid lineage 49.2 6 3.9 50.2 6 5.0 59.4 6 2.9 48.7 6 5.4
Erythroid lineage 16.3 6 2.3 15.4 6 0.8 23.4 6 1.3 24.3 6 2.2
Myeloid/erythroid ratio 2.2 6 0.6 2.2 6 0.2 0.7 6 0.1 1.1 6 0.2
Cell counts and 500-count manual leukocyte differentials were performed on nucleated cells recovered from the femurs of six to eight age-
matched mice of each genotype. Data represent the mean 6 SD.
ap , 0.01 compared with 1/1 or 1/2 mice.
bp , 0.01 compared with 2/2 mice.
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Figure 2. Hematopoietic Progenitor Assays
Bone marrow cells were plated in methylcel-
lulose-containing medium supplemented with
a cocktail of recombinant cytokines or, in the
case of CFU-G, with G-CSF (100 ng/ml) alone.
Standard morphologic criteria were used to
score colonies containing greater than 50
cells. Asterisk, colonies containing 10±25
cells. Data represent the mean 6 SD.
we examined the response of GE/GE bone marrow cells MMP-9 (gelatinase B) is expressed during the metamy-
elocyte/band cell stage of granulocytic differentiation andto G-CSF alone. Under these conditions, similar numbers
of colonies were observed in cultures of 1/1, 1/2, and is therefore considered a marker of terminal granulocytic
differentiation (Borregaard and Cowland, 1997). Its ex-GE/GE cells. However, while 1/1 and 1/2 bone marrow
cells produced colonies containing hundreds of cells, pression in GE/GE neutrophils is comparable to 1/1
neutrophils as assessed by immunohistochemistry andGE/GE cells only produced small clusters containing
10±25 cells. Cytological examination of G-CSF-stimu- gelatin zymography (Figure 4; data not shown). Finally,
neutrophils from GE/GE mice express levels of Gr-1 andlated colonies demonstrated that each colony was com-
prised primarily of mature neutrophils (data not shown). CDllb (Mac-1) that are comparable to 1/1 neutrophils
(data not shown).These data suggest that G:EpoR expression does not
affect lineage commitment and supports granulocytic
differentiation. G-CSF-Stimulated Neutrophil and Hematopoietic
Progenitor Cell Mobilization Is Impaired
in GE/GE MiceG-CSF Stimulates Granulopoiesis but Not
Erythropoiesis in GE/GE Mice As noted above, G-CSF treatment of GE/GE mice re-
sulted in a bone marrow neutrophil count similar to thatTo examine if G-CSF would stimulate erythropoiesis in
vivo, as might be predicted by the instructive model, seen in wild-type mice. Surprisingly, despite the in-
crease in bone marrow neutrophils, little increase in cir-GE/GE mice were treated with high-dose G-CSF (250
mg/kg/day). After 7 days of treatment, no significant culating neutrophils was seen, suggesting a defect in
neutrophil release from the bone marrow (Figure 3B). Indifferences were detected in the number of bone marrow
BFU-E or the level of circulating reticulocytes or red addition to neutrophils (Lieschke et al., 1994), G-CSF
stimulates the mobilization of hematopoietic progenitorblood cells in GE/GE mice (Figure 3A), indicating that
G-CSF treatment had no affect on the erythroid com- cells (HPC) from the bone marrow to blood (Molineux
et al., 1990a, 1990b; de Haan et al., 1995). We thereforepartment. The major effect of G-CSF treatment in GE/
GE mice was the stimulation of granulopoiesis. A 3-fold examined HPC mobilization in GE/GE mice following
G-CSF treatment. In wild-type mice, G-CSF treatmentincrease in bone marrow neutrophils was observed in
GE/GE mice, resulting in a bone marrow neutrophil count resulted in a 22- and 13-fold increase in blood and
spleen HPC, respectively (Figure 5). In contrast, no sig-similar to that seen in G-CSF-treated 1/1 or 1/2 mice
(Figure 3B). Similar results were obtained after treatment nificant increase in blood or spleen HPC was observed
in GE/GE mice, despite normal numbers of bone marrowof a separate cohort of mice with 10 mg/kg/day of G-CSF
for 7 days (data not shown). HPC. These data indicate that signals generated by
G:EpoR are not able to support G-CSF-stimulated neu-
trophil or HPC mobilization from the bone marrow.G:EpoR Signals Support Granulocytic
Differentiation In Vivo
In order to determine whether G:EpoR is able to support GE/GE Neutrophils Demonstrate Impaired
Chemotaxis to Interleukin-8the development of phenotypically normal neutrophils,
several markers associated with neutrophil maturation One possible mechanism for the defect in neutrophil
mobilization in GE/GE mice is impaired neutrophil migra-were analyzed. Neutrophils were isolated from GE/GE
mice following high-dose G-CSF treatment to minimize tion. In fact, we recently showed that 2/2 neutrophils
have impaired chemotaxis and adhesion in response tothe effect of other cytokines on granulocytic differentia-
tion. GE/GE neutrophils have normal morphology as as- IL-8, macrophage inhibitory protein-2 (MIP-2), fMLP, or
zymosan-activated serum, suggesting that G-CSFR sig-sessed by Wright-Giemsa staining, and they stain posi-
tively for chloroacetate esterase, a specific marker of nals are required for normal chemokine-induced neutro-
phil activation and migration (Betsuyaku et al., 1999).the granulocyte lineage (Figure 4) (Yam et al., 1971).
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Figure 3. Hematopoietic Response to G-CSF
Treatment
Mice were treated with human G-CSF (250
mg/kg/day) for 7 days and the erythroid (A)
and neutrophil (B) response measured. The
level of circulating reticulocytes, RBCs, and
bone marrow BFU-E and the number of circu-
lating and bone marrow neutrophils were an-
alyzed before the first injection (day 0) and 4
hr after the final injection (day 7). Data repre-
sent the mean 1 SD.
To determine if G:EpoR could provide these signals, we Discussion
examined the chemotactic response of GE/GE neutro-
phils to IL-8. IL-8 was chosen for these experiments, The instructive model of hematopoietic differentiation
states that hematopoietic growth factors play a role inbecause the defect in 2/2 neutrophil chemotaxis was
most striking in response to IL-8 and because murine directing lineage commitment (reviewed in D'Andrea,
1994). This model therefore predicts that the substitu-IL-8 receptor ortholog expression is normal on 2/2 neu-
trophils (Betsuyaku et al., 1999). As expected, 2/2 neu- tion of erythropoietin-specific signals for those of the
G-CSFR might result in a redirection of hematopoiesis intotrophils demonstrated significantly reduced chemotaxis
compared with 1/1 or 1/2 neutrophils (Figure 6). Sur- the erythroid lineage. However, erythropoiesis appears to
be normal in GE/GE mice. At baseline, the level of circu-prisingly, a similar defect in IL-8-induced chemotaxis
was detected with GE/GE neutrophils. lating RBCs and reticulocytes and number of BFU-E in
Figure 4. Cytological Analysis of GE/GE Neu-
trophils
Bone marrow cells were isolated after 7 days
of treatment with human G-CSF (250 mg/kg/
day) and analyzed by Wright-Giemsa stain,
chloroacetate esterase cytochemistry, and
MMP-9 immunohistochemistry. Arrows indi-




Figure 5. HPC Mobilization
Mice were treated with human G-CSF (n 5 6;
250 mg/kg/day) or saline (n 5 3) for 7 days
and the colony-forming cell (CFU-C) content
of bone marrow, blood, and spleen quanti-
fied. Data represent the mean 6 SD.
the bone marrow are normal. Furthermore, no changes results in a significant stimulation of granulopoiesis. In
fact, since the great majority of neutrophils reside withinin these parameters were noted after high-dose G-CSF
treatment. G:EpoR expression also had no apparent af- the bone marrow, the total body number of neutrophils
in GE/GE mice following G-CSF treatment is similar tofect on commitment to the myeloid lineage since the
number of myeloid-committed progenitors (CFU-GM that seen in wild-type mice. The mechanism(s) responsi-
ble for the impaired granulopoiesis in GE/GE mice isand CFU-G) in the bone marrow of GE/GE mice was
normal. Using a similar approach, Stoffel et al. (1999) currently not known. The normal number of myeloid
progenitors (CFU-GM and CFU-G) in the bone marrowrecently showed that a chimeric receptor comprised of
the extracellular and transmembrane domains of c-mpl of these mice suggests a defect in the expansion and/
or differentiation of these progenitors. In agreement withfused to the cytoplasmic domain of the G-CSFR was
able to support near normal megakaryopoiesis and this hypothesis, the size of G-CSF-stimulated colonies
in cultures of GE/GE bone marrow cells was significantlyplatelet production. Collectively, these data provide
reduced compared to cultures of 1/1 or 1/2 cells (thestrong evidence that signals generated by the cyto-
near normal neutrophil response to high-dose G-CSFplasmic domain of hematopoietic cytokines do not play
in GE/GE mice likely reflects the contribution of othera significant role in directing lineage commitment. It
cytokines). The expression of G:EpoR on myeloid pro-should be noted that, while the transduction of signals
genitors was not directly measured in this study; there-has generally been localized to the cytoplasmic domain,
fore, it is possible that the defect in G-CSF-dependentit is formally possible that signals generated by the ex-
colony formation is secondary to decreased receptortracellular and transmembrane regions of these recep-
expression. However, the defect in G-CSF-dependenttors may be directing lineage commitment.
colony formation is unlikely to be solely attributed toA major phenotype of GE/GE mice is a defect in gran-
decreased G:EpoR expression since a similarly reducedulopoiesis. At baseline, these mice have significant de-
level of G-CSFR expression on 1/2 hematopoietic cellscreases in circulating and bone marrow neutrophils to
supports normal colony formation. These data thereforelevels approaching that seen in mice lacking any func-
indicate that G:EpoR signals are not able to efficientlytional G-CSFR (Liu et al., 1996). However, in sharp con-
support the proliferation and/or survival of granulocytictrast to G-CSFR-deficient mice, treatment with G-CSF
precursors.
A major area of controversy in hematopoietic growth
factor research is the contribution of hematopoietic cy-
tokine receptor signals to the terminal differentiation of
hematopoietic cells. With respect to granulocytic differ-
entiation, specific G-CSFR signals have been implicated
in the terminal granulocytic differentiation of certain he-
matopoietic cell lines (Dong et al., 1993; Fukunaga et
al., 1993; Ziegler et al., 1993; Yoshikawa et al., 1995;
Shimozaki et al., 1997). In particular, signals generated
by the carboxy-terminal region of the cytoplasmic do-
main of the G-CSFR have been implicated, since this
region is deleted in a subset of patients with severe
congenital neutropenia and since cell lines expressing
this truncated G-CSFR have impaired granulocytic dif-
ferentiation (Dong et al., 1994, 1995). However, we re-
Figure 6. Chemotaxis cently showed that mice carrying a targeted mutation of
Neutrophils were purified from the bone marrow of mice after 7 days their G-CSFR that reproduces this mutation have normal
of treatment with human G-CSF (250 mg/kg/day). Chemotaxis was basal granulopoiesis (McLemore et al., 1998).
assayed in a modified Boyden chamber in response to buffer alone
In the present study, we show that G:EpoR signals(HBSS) or human interleukin-8 (3 mg/ml). The average number of
are able to support the production of morphologicallyneutrophils per high-power field (HPF) 6 SD of triplicate samples
is shown. Data are representative of three separate experiments. mature neutrophils. Neutrophils isolated from GE/GE
Role of Cytokines in Hematopoiesis
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TCCAAGATCTGGCCTGGCA-39) containing a XmnI site and a re-mice after G-CSF stimulation share several features nor-
verse primer (59-AATCTAGACTAGGAGCAGGCCACATAG-39) con-mally associated with mature neutrophils, including nor-
taining an Xba1 site. The resulting 690 bp amplicon was digestedmal morphology and normal expression of chloroace-
with XmnI and Xba1 and subcloned into a p15-17 that had been
tate esterase, MMP-9 (gelatinase B), Gr-1, and Mac-1 digested with XmnI and Xba1. Sequence analysis was performed
(Cdllb). However, GE/GE neutrophils are not phenotypi- to confirm the fidelity of this construct. The 3 kb genomic fragment
from p15±17 (containing the mutation) along with a 2.8 kb HindIII±cally normal. As noted below, neutrophil release from
BamHI genomic fragment containing the 39-flanking region of thethe bone marrow is impaired, and GE/GE neutrophils
murine G-CSFR gene were subcloned 59 and 39, respectively, to ademonstrate markedly decreased chemotaxis in re-
1.8 kb PGK-neor cassette to generate the targeting vector (Figure 1B).sponse to IL-8. Thus, G:EpoR signals, while able to sup-
port some aspects of granulocytic differentiation, can-
Production of G:EpoR Micenot support a fully functional neutrophil phenotype. This
RW4 ES cells (a gift from T. J. Ley, Washington University, St. Louis,
result suggests that unique G-CSFR signals regulate MO) were transfected with the Nsi-1-linearized targeting vector, and
specific neutrophil biological activities. In a similar fash- G418-resistant clones were isolated essentially as described (Hug
ion, GM-CSF may provide unique signals required for et al., 1996). Clones that had undergone homologous recombination
were identified by Southern analysis of EcoR1-digested genomicnormal macrophage function, since mice lacking a func-
DNA using a 0.4 kb EcoR1±Xho1 genomic fragment (Figure 1B) astional GM-CSF gene display normal basal hematopoie-
an external probe. Two out of ninety-three G418-resistant clonessis but have a defect in macrophage function that leads
were identified in this fashion. C57BL/6 blastocysts were microin-
to a clinical syndrome with features of pulmonary alveo- jected with ES cells from each of these clones and implanted into
lar proteinosis (Dranoff et al., 1994; Stanley et al., 1994). pseudopregnant Swiss Webster foster females, as described pre-
A striking and unexpected finding of the current study viously (Hug et al., 1996). Chimeric males with a high percentage of
agouti coat color were mated with C57BL/6 females and their off-is the failure of treatment with G-CSF to mobilize neutro-
spring examined for germline transmission of the targeted G-CSFRphils or HPC from the bone marrow into the circulation
mutation using the Southern analysis procedure described above.in GE/GE mice. Even in untreated GE/GE mice, the se-
Heterozygous mice derived from one of the targeted ES clones were
verity of neutropenia is out of proportion to the neutro- intercrossed to produce homozygous mutant mice. All mice were
phil content in the bone marrow. Although a decrease housed in a specific pathogen-free environment and examined daily
in neutrophil survival in the circulation could account by veterinary staff for signs of illness.
for the disproportionately severe neutropenia in GE/GE
mice, collectively these findings are most consistent Analysis of mRNA Expression
Total RNA was prepared from bone marrow mononuclear cells usingwith a defect in neutrophil and HPC release from the
a guanidinium thiocyanate mini-prep as described (Chomczynskibone marrow in response to G-CSF. This hypothesis
and Sacchi, 1987). Approximately 1 mg of RNA was treated withpredicts that nonredundant G-CSFR signals normally
DNase for 15 min and was then reverse transcribed using randomplay a critical role in regulating neutrophil and HPC mobi-
primers and AMV-reverse transcriptase (Promega, Madison, WI).
lization from the bone marrow. In agreement with this The cDNA was amplified using a murine G-CSFR exon 15 forward
hypothesis, we previously showed that neutrophil and primer (59-GTACTCTTGTCCACTACCTGT-39) and an exon 17 reverse
primer (59-CAAGATACAAGGACCCCCAA-39) for 30 cycles at 988Cprogenitor mobilization after treatment with cyclophos-
for 45 sec, 568C for 45 sec, and 728C for 1 min. The PCR productsphamide or IL-8 is markedly impaired in G-CSFR-defi-
were resolved using a 1.5% agarose gel.cient mice (Liu et al., 1997). Moreover, we recently
showed that a functional G-CSFR on hematopoietic cells
Flow Cytometrybut not stromal cells is required for these processes
Red blood cells in peripheral blood and bone marrow mononuclear(unpublished data). Whether the defect in neutrophil mi-
cell preparations were lysed in Tris-buffered ammonium chloride
gration contributes to the defect in neutrophil release (pH 7.2) buffer and incubated with the indicated antibody at 48C
from the bone marrow will require further investigation. for 1 hr in PBS containing 0.1% sodium azide and 0.2% bovine
In summary, this study provides evidence in support serum albumin. The following directly conjugated antibodies were
used: Phycoerythrin (PE)±conjugated rat anti-mouse CD11b (M1/of the stochastic model of hematopoietic differentiation
70,IgG2b; PharMingen) and Fluorescein isothiocyanate (FITC)-con-in which hematopoietic growth factors provide growth
jugated rat anti mouse Gr-1(RB6-8C5, IgG2b; PharMingen). To as-and survival signals but do not direct terminal differenti-
sess surface G-CSFR expression, peripheral blood mononuclear
ation. However, the signals generated by hematopoietic cells were incubated at 48C for 1 hr with biotinylated G-CSF (gener-
growth factors are not completely interchangeable. ated as described [Liu et al., 1996]; 5 ng per 106 cells) in the presence
Unique signals generated by hematopoietic growth fac- or absence of a 100-fold molar excess of nonlabeled G-CSF, fol-
lowed by incubation with RPE-Cy5-conjugated streptavidin (Dako).tor receptors appear to play a significant role in the
The neutrophil population was gated based on forward- and side-regulation of mature hematopoietic cell function. Thus,
scatter characteristics. To assess the level of circulating reticulo-the need to selectively regulate the function of specific
cytes, peripheral blood was incubated for 30 min at room tempera-
populations of mature hematopoietic cells may explain ture in 1 mg/ml acridine orange (Molecular Probes) in PBS containing
the diversity within the signaling domains of the hemato- 0.1% sodium azide and 0.2% bovine serum albumin (Schmitz and
poietic growth factor receptor family. Werner, 1986). All cells were analyzed using a FACScan flow cyto-
meter and CellQuest version 1.2.2 software (Becton-Dickinson).
Experimental Procedures
G-CSF Binding Experiments
Binding experiments were performed as previously described withConstruction of the Targeting Vector
The molecular cloning of the murine G-CSFR gene has been de- minor modifications (Watanabe et al., 1991). In brief, 5.0 3 106 bone
marrow cells were incubated in triplicate with eight different concen-scribed previously (Liu et al., 1996). A 3 kb BamHI±HindIII genomic
fragment containing exons 15±17 was subcloned into pUC-9 (hereaf- trations of 125I-[Tyr1, Tyr3]rhG-CSF for 3 hr at 158C in the presence
or absence of at least a 50-fold excess of unlabeled rhG-CSF. Cellter termed p15±17). A murine erythropoietin cDNA was used as the
template in a PCR reaction using a forward primer (59-AAGAAAGACT bound versus free 125I-[Tyr1, Tyr3]rhG-CSF was measured using a
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LKB-Wallac CliniGamma 1272±004 gamma counter (Wallac Oy, Fin- for his expert technical assistance and helpful discussions. This
work was supported by the Edward Mallinckrodt, Jr., Foundationland). Dissociation constants (Kd) were calculated from two indepen-
dent experiments. 125I-[Tyr1, Tyr3]rhG-CSF was kindly provided by (D. C. L.), by a grant from Monsanto/Searle (D. C. L.), and by a
training grant from the National Institutes of Health National Heart,Monsanto/Searle.
Lung, and Blood Institute (T 32 HL 07088-23; C. L. S.).
Peripheral Blood and Bone Marrow Analysis
Blood was obtained by retroorbital venous plexus sampling in poly- Received March 12, 1999; revised June 23, 1999.
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